Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting Remission in Moderate-to-Severe Crohn's Disease.

Troy Kish

    P & T : a Peer-Reviewed Journal for Formulary Management
    |June 14, 2018
    PubMed
    Summary

    New therapeutic options are emerging for Crohn's disease treatment, including small-molecule drugs and targeted monoclonal antibodies. This diverse pipeline offers a broad range of approaches for this complex condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hepatotoxicity With Elevated Bilirubin Secondary to Prophylactic Doses of Unfractionated Heparin: A Case Report and Review of Heparin-Induced Hepatotoxicity.

    The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2021
    Same author

    Promising Multiple Sclerosis Agents In Late-Stage Development.

    P & T : a peer-reviewed journal for formulary management·2018
    Same author

    Emerging Therapies for Patients With Difficult-to-Treat Migraine.

    P & T : a peer-reviewed journal for formulary management·2018
    Same author

    Risk Reduction to Disease Management: Clinical Pharmacists as Cardiovascular Care Providers.

    Current problems in cardiology·2018
    Same author

    Old and New Drug Classes Expanding To Include Glaucoma Treatments.

    P & T : a peer-reviewed journal for formulary management·2018
    Same author

    The role of the pharmacist in hypertension management.

    Current opinion in cardiology·2018

    Area of Science:

    • Gastroenterology
    • Immunology
    • Pharmacology

    Background:

    • Crohn's disease is a complex inflammatory bowel disease with significant unmet medical needs.
    • Current treatment strategies for Crohn's disease have limitations, necessitating the development of novel therapies.

    Purpose of the Study:

    • To provide an overview of the therapeutic pipeline for Crohn's disease.
    • To highlight the diverse range of novel treatment modalities under investigation.

    Main Methods:

    • Review of the current landscape of investigational drugs for Crohn's disease.
    • Categorization of therapeutic candidates into small molecules and monoclonal antibodies.

    Main Results:

    • The active pipeline for Crohn's disease includes a variety of small-molecule inhibitors targeting specific inflammatory pathways.
    • Development is also progressing with targeted monoclonal antibodies designed to modulate immune responses.

    Conclusions:

    • The breadth of the therapeutic pipeline indicates significant advancements in addressing Crohn's disease.
    • Future treatments for Crohn's disease are likely to involve a combination of small molecules and biologics, offering personalized therapeutic strategies.

    Related Experiment Videos